Sorrento Therapeutics, Inc. - 23 Nov 2022 Form 4 Insider Report for Scilex Holding Company/DE (SCLX)

Role: 10%+ Owner
Signature: /s/ Henry Ji, Ph.D., President, Chief Executive Officer and Chairman of the Board, Sorrento Therapeutics, Inc.
Issuer symbol: SCLX
Transactions as of: 23 Nov 2022
Net transactions value: +$175,670
Form type: 4
Filing time: 23 Nov 2022, 16:59:05 UTC
Previous filing: 22 Nov 2022
Next filing: 25 Nov 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SCLX	Warrants to Purchase Common Stock	Purchase	$175,670	+442,829	+12%	$0.3967	4,219,604	23 Nov 2022	Common Stock	442,829	$11.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2444 to $0.45 per warrant, inclusive. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, full information regarding the number of warrants purchased at each separate price.

Content

The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.2444 to $0.45 per warrant, inclusive. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or a securityholder of the Issuer, full information regarding the number of warrants purchased at each separate price.